Change in Healthcare Utilization and costs in Patients with Major Depressive Disorder (MDD) initiating adjunctive Therapy with Second-Generation Antipsychotics (SGAS)

Hagiwara, M ; Sun, S.X ; Moynahan, A ; Bornheimer, R ; Oster, G

Value in health, 2015-05, Vol.18 (3), p.A119-A119 [Periódico revisado por pares]

Texto completo disponível